ATE334123T1 - 9,11-cycloendoperoxyd prodrugs von prostaglandinanalogen für die behandlung von okularer hypertension und glaukoma - Google Patents
9,11-cycloendoperoxyd prodrugs von prostaglandinanalogen für die behandlung von okularer hypertension und glaukomaInfo
- Publication number
- ATE334123T1 ATE334123T1 AT03767129T AT03767129T ATE334123T1 AT E334123 T1 ATE334123 T1 AT E334123T1 AT 03767129 T AT03767129 T AT 03767129T AT 03767129 T AT03767129 T AT 03767129T AT E334123 T1 ATE334123 T1 AT E334123T1
- Authority
- AT
- Austria
- Prior art keywords
- cycloendoperoxyde
- glaucoma
- prodrugs
- prostaglandin
- treatment
- Prior art date
Links
- 229940006138 antiglaucoma drug and miotics prostaglandin analogues Drugs 0.000 title abstract 2
- 229940002612 prodrug Drugs 0.000 title abstract 2
- 239000000651 prodrug Substances 0.000 title abstract 2
- 208000010412 Glaucoma Diseases 0.000 title 1
- 206010020772 Hypertension Diseases 0.000 title 1
- 229940079593 drug Drugs 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 208000001953 Hypotension Diseases 0.000 abstract 1
- -1 Latanaprost Chemical compound 0.000 abstract 1
- 229960002470 bimatoprost Drugs 0.000 abstract 1
- AQOKCDNYWBIDND-FTOWTWDKSA-N bimatoprost Chemical compound CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1 AQOKCDNYWBIDND-FTOWTWDKSA-N 0.000 abstract 1
- 208000021822 hypotensive Diseases 0.000 abstract 1
- 230000001077 hypotensive effect Effects 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 230000004962 physiological condition Effects 0.000 abstract 1
- GOUQZQORWGWEFM-WLOFLUCMSA-N prostaglandin H2 1-ethanolamide Chemical compound C1[C@@H]2OO[C@H]1[C@H](/C=C/[C@@H](O)CCCCC)[C@H]2C\C=C/CCCC(=O)NCCO GOUQZQORWGWEFM-WLOFLUCMSA-N 0.000 abstract 1
- 150000003180 prostaglandins Chemical class 0.000 abstract 1
- 230000002459 sustained effect Effects 0.000 abstract 1
- 229960002368 travoprost Drugs 0.000 abstract 1
- MKPLKVHSHYCHOC-AHTXBMBWSA-N travoprost Chemical compound CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC=CC(C(F)(F)F)=C1 MKPLKVHSHYCHOC-AHTXBMBWSA-N 0.000 abstract 1
- 229960004317 unoprostone Drugs 0.000 abstract 1
- TVHAZVBUYQMHBC-SNHXEXRGSA-N unoprostone Chemical compound CCCCCCCC(=O)CC[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O TVHAZVBUYQMHBC-SNHXEXRGSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/02—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 2
- C07D317/06—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 2 condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/212,437 US6864282B2 (en) | 2002-08-05 | 2002-08-05 | 9,11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE334123T1 true ATE334123T1 (de) | 2006-08-15 |
Family
ID=31187772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03767129T ATE334123T1 (de) | 2002-08-05 | 2003-08-04 | 9,11-cycloendoperoxyd prodrugs von prostaglandinanalogen für die behandlung von okularer hypertension und glaukoma |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6864282B2 (enExample) |
| EP (2) | EP1527063B1 (enExample) |
| JP (1) | JP2005539014A (enExample) |
| AT (1) | ATE334123T1 (enExample) |
| AU (1) | AU2003261352A1 (enExample) |
| CA (1) | CA2494146A1 (enExample) |
| DE (1) | DE60307106T2 (enExample) |
| ES (1) | ES2268433T3 (enExample) |
| WO (1) | WO2004013119A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7070768B2 (en) * | 2003-09-25 | 2006-07-04 | Allergan, Inc. | Method for imparting artificial tan to human skin |
| GB0501192D0 (en) * | 2005-01-20 | 2005-03-02 | Resolution Chemicals Ltd | Stable prostaglandin-containing compositions |
| WO2010102078A1 (en) | 2009-03-04 | 2010-09-10 | Allergan, Inc. | Enhanced bimatoprost ophthalmic solution |
| US7851504B2 (en) * | 2005-03-16 | 2010-12-14 | Allergan, Inc. | Enhanced bimatoprost ophthalmic solution |
| EP1916002B1 (en) | 2005-08-02 | 2014-03-05 | Santen Pharmaceutical Co., Ltd. | Method for prevention of degradation of thermally unstable substance |
| WO2007111806A2 (en) | 2006-03-23 | 2007-10-04 | Massachusetts Eye And Ear Infirmary | Cyclopentane heptanoic acid compounds for reducing body fat |
| US20110293549A1 (en) | 2009-02-03 | 2011-12-01 | Athena Cosmetics, Inc. | Composition, method and kit for enhancing hair |
| US9522153B2 (en) | 2009-12-22 | 2016-12-20 | Allergan, Inc. | Compositions and methods for lowering intraocular pressure |
| ES2687494T3 (es) | 2011-01-19 | 2018-10-25 | Topokine Therapeutics, Inc. | Métodos y composiciones para reducir la grasa corporal |
| US8426471B1 (en) | 2011-12-19 | 2013-04-23 | Topokine Therapeutics, Inc. | Methods and compositions for reducing body fat and adipocytes |
| CA2869676C (en) | 2012-11-21 | 2015-06-23 | Topokine Therapeutics, Inc. | Uses and compositions comprising a thiazolidinedione and oleic acid for locally increasing subcutaneous fat |
| NO2753788T3 (enExample) | 2013-05-10 | 2018-06-16 | ||
| WO2014186504A1 (en) | 2013-05-15 | 2014-11-20 | Topokine Therapeutics, Inc. | Methods and compositions for topical delivery of prostaglandins to subcutaneous fat |
| US9115109B2 (en) * | 2013-08-15 | 2015-08-25 | Chirogate International Inc. | Processes and intermediates for the preparations of isomer free prostaglandins |
| US10188661B2 (en) | 2014-06-27 | 2019-01-29 | Topokine Therapeutics, Inc. | Topical dosage regimen |
| EP3675866B1 (en) | 2017-09-01 | 2023-08-02 | East Carolina University | Ex vivo methods for activating immune cells |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4599353A (en) * | 1982-05-03 | 1986-07-08 | The Trustees Of Columbia University In The City Of New York | Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma |
| US4867915A (en) * | 1986-05-21 | 1989-09-19 | Syntex (U.S.A.) Inc. | 16-Substituted polyunsaturated hexadecanoic fatty acids |
| ES2213504T1 (es) | 1988-09-06 | 2004-09-01 | Pfizer Health Ab | Derivados de prostaglandina para el tratamiento del glaucoma o hipertension ocular. |
| US5767154A (en) | 1991-02-07 | 1998-06-16 | Allergan | 5-trans-prostaglandins of the F series and their use as ocular hypotensives |
| US5352708A (en) * | 1992-09-21 | 1994-10-04 | Allergan, Inc. | Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| US5385945A (en) | 1992-10-21 | 1995-01-31 | Allergan, Inc. | 7-(5-substituted cyclopentyl) and (5-substituted cyclopentenyl) heptyl alcohols, heptylamines and heptanoic acid amides, and method of lowering intraocular pressure in the eye of a mammal by administration of these novel compounds |
| US5510383A (en) * | 1993-08-03 | 1996-04-23 | Alcon Laboratories, Inc. | Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension |
| ATE326972T1 (de) | 1997-10-13 | 2006-06-15 | R Tech Ueno Ltd | Heilende zusammensetzung für intraokulare hypertension oder glaukom |
| US6066671A (en) | 1997-12-19 | 2000-05-23 | Alcon Laboratories, Inc. | Treatment of GLC1A glaucoma with 3-benzoyl-phenylacetic acids, esters, or amides |
| DE60137335D1 (de) | 2000-08-07 | 2009-02-26 | Univ Vanderbilt | Nachweis der COX-2 Aktivität und von Anandamid-Metaboliten |
-
2002
- 2002-08-05 US US10/212,437 patent/US6864282B2/en not_active Expired - Fee Related
-
2003
- 2003-08-04 CA CA002494146A patent/CA2494146A1/en not_active Abandoned
- 2003-08-04 DE DE60307106T patent/DE60307106T2/de not_active Expired - Fee Related
- 2003-08-04 AU AU2003261352A patent/AU2003261352A1/en not_active Abandoned
- 2003-08-04 WO PCT/US2003/024305 patent/WO2004013119A1/en not_active Ceased
- 2003-08-04 EP EP03767129A patent/EP1527063B1/en not_active Expired - Lifetime
- 2003-08-04 JP JP2004526380A patent/JP2005539014A/ja active Pending
- 2003-08-04 ES ES03767129T patent/ES2268433T3/es not_active Expired - Lifetime
- 2003-08-04 AT AT03767129T patent/ATE334123T1/de not_active IP Right Cessation
- 2003-08-04 EP EP06011653A patent/EP1731516A3/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| US20040023954A1 (en) | 2004-02-05 |
| EP1527063B1 (en) | 2006-07-26 |
| ES2268433T3 (es) | 2007-03-16 |
| JP2005539014A (ja) | 2005-12-22 |
| DE60307106T2 (de) | 2007-02-22 |
| DE60307106D1 (de) | 2006-09-07 |
| US6864282B2 (en) | 2005-03-08 |
| EP1731516A3 (en) | 2007-01-03 |
| AU2003261352A1 (en) | 2004-02-23 |
| EP1527063A1 (en) | 2005-05-04 |
| EP1731516A2 (en) | 2006-12-13 |
| CA2494146A1 (en) | 2004-02-12 |
| WO2004013119B1 (en) | 2004-05-06 |
| WO2004013119A1 (en) | 2004-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60307106D1 (de) | 9,11-cycloendoperoxyd prodrugs von prostaglandinanalogen für die behandlung von okularer hypertension und glaukoma | |
| FI902258A0 (fi) | Menetelmä farmakologisesti aktiivisten 13,14-dihydro-17-fenyyli-18,19,20-trinor-PGF2 -alkyyliestereiden valmistamiseksi | |
| DE60334134D1 (de) | Ungsmethode von erhöhtem augeninnendruck und glaukom | |
| WO2003103575A3 (en) | Compounds, compositions, and methods | |
| LU92509I2 (fr) | Travoprost et ses dérivés pharmaceutiquement acceptables (TRAVATAN) | |
| DE69634414D1 (de) | Verwendung von substituierten isochinolinsulfonyl-verbindungen zur herstellung eines medikaments für die behandlung von glaukom und okularer ischämie | |
| DK1039895T3 (da) | Anvendelse af 3-benzoylphenyleddikesyrer, estere eller amider til behandling af GLC1A-glaukom | |
| ATE78031T1 (de) | Prostaglandin-derivate zur behandlung von glaucoma oder augenueberdruck. | |
| ATE319458T1 (de) | Medizinische zusammensetzungen zur behandlung von augenerkrankungen | |
| BR0012696A (pt) | Composição oftálmica | |
| CY1110644T1 (el) | 5,6,7-τριυδροξυεπτανοϊκο οξυ και τα αναλογα για την θεραπεια οφθαλμικων ασθενειων που σχετιζονται με υπερεκφυτικες και αγγειογενεις αντιδρασεις | |
| BR0008776A (pt) | Análogos de prostaglandinas fp-seletivosinsaturados c16 | |
| DE60003435D1 (de) | Neue 2-decarboxy-2-phosphinico prostaglandin f analoge | |
| CA2364944A1 (en) | C16 unsaturated fp-selective prostaglandins analogs | |
| ATE216889T1 (de) | Anwendung von prostagrandin-analogen für die behandlung von glaukome und okuläre hypertension | |
| ATE326972T1 (de) | Heilende zusammensetzung für intraokulare hypertension oder glaukom | |
| SE9401087D0 (sv) | New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension | |
| DE69829227D1 (de) | Arzneimittelzusammenstellung zur behandlung des erhöhten augeninnendrucks oder des glaukom | |
| EP1051973A4 (en) | OPTICAL PAPILLAR CIRCULATION IMPROVING AGENTS | |
| AR023192A1 (es) | Analogos de las flint resistentes a proteasas | |
| PT91816A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo derivados de prostaglandinas para tratamento de glaucoma ou hipertensao ocular |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |